Spark Therapeutics, Inc. announced the resignation of John P. Furey as Chief Operating Officer of the company, effective January 1, 2019. In connection with Mr. Furey's resignation, Mr. Furey has agreed to provide consulting services on an as needed basis to the company through June 28, 2019 to assist with the transition of his responsibilities.